FDA.reportPublic FDA data

Application 202551

Type
ANDA
Sponsor
WATSON LABS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SOLIFENACIN SUCCINATESOLIFENACIN SUCCINATETABLET;ORAL5MGNoNo
002SOLIFENACIN SUCCINATESOLIFENACIN SUCCINATETABLET;ORAL10MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0591-3795Solifenacin succinatesolifenacin succinateActavis Pharma, Inc.ANDACurrent
0591-3795Solifenacin succinatesolifenacin succinateActavis Pharma, Inc.ANDACurrent
0591-3795Solifenacin succinatesolifenacin succinateActavis Pharma, Inc.ANDACurrent
0591-3795Solifenacin succinatesolifenacin succinateActavis Pharma, Inc.ANDACurrent
0591-3795Solifenacin succinatesolifenacin succinateActavis Pharma, Inc.ANDACurrent
0591-3796Solifenacin succinatesolifenacin succinateActavis Pharma, Inc.ANDACurrent
0591-3796Solifenacin succinatesolifenacin succinateActavis Pharma, Inc.ANDACurrent
0591-3796Solifenacin succinatesolifenacin succinateActavis Pharma, Inc.ANDACurrent
0591-3796Solifenacin succinatesolifenacin succinateActavis Pharma, Inc.ANDACurrent
0591-3796Solifenacin succinatesolifenacin succinateActavis Pharma, Inc.ANDACurrent
0591-3796Solifenacin succinatesolifenacin succinateActavis Pharma, Inc.ANDACurrent